Bidness Etc |
GlaxoSmithKline grabs FDA approval for its latest asthma treatment
FierceBiotech "The approval of Arnuity Ellipta is an important development for GSK and our expanding respiratory portfolio," Senior Vice President Darrell Baker said in a statement. "It is the first asthma treatment from our new portfolio to have gained approval in … GSK's Asthma Treatment Gets FDA Approval FDA OKs New Maintenance Asthma Treatment Arnuity Ellipta FDA approves GSK asthma medicine |
View full post on asthma – Google News